Literature DB >> 30370099

Epithelial-mesenchymal transition-induced metastasis could be a bait for natural killer cells.

Riki Okita1, Katsuhiko Shimizu2, Masao Nakata2.   

Abstract

Year:  2018        PMID： 30370099      PMCID： PMC6186618          DOI： 10.21037/jtd.2018.08.19

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM.

Authors:  Kent S Boles; Winfried Barchet; Tom Diacovo; Marina Cella; Marco Colonna
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

2.  Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.

Authors:  Peter J Chockley; Jun Chen; Guoan Chen; David G Beer; Theodore J Standiford; Venkateshwar G Keshamouni
Journal:  J Clin Invest       Date:  2018-02-26       Impact factor: 14.808

3.  Human NK cell education by inhibitory receptors for MHC class I.

Authors:  Nicolas Anfossi; Pascale André; Sophie Guia; Christine S Falk; Sophie Roetynck; C Andrew Stewart; Violette Breso; Coralie Frassati; Denis Reviron; Derek Middleton; François Romagné; Sophie Ugolini; Eric Vivier
Journal:  Immunity       Date:  2006-08-10       Impact factor: 31.745

Review 4.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Nat Rev Clin Oncol       Date:  2017-04-11       Impact factor: 66.675

5.  Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction.

Authors:  Christoph Uherek; Torsten Tonn; Barbara Uherek; Sven Becker; Barbara Schnierle; Hans-Georg Klingemann; Winfried Wels
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

6.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

8.  CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.

Authors:  François Ghiringhelli; Cédric Ménard; Magali Terme; Caroline Flament; Julien Taieb; Nathalie Chaput; Pierre E Puig; Sophie Novault; Bernard Escudier; Eric Vivier; Axel Lecesne; Caroline Robert; Jean-Yves Blay; Jacky Bernard; Sophie Caillat-Zucman; Antonio Freitas; Thomas Tursz; Orianne Wagner-Ballon; Claude Capron; William Vainchencker; François Martin; Laurence Zitvogel
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

9.  Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.

Authors:  Riki Okita; Diana Wolf; Koichiro Yasuda; Ai Maeda; Takuro Yukawa; Shinsuke Saisho; Katsuhiko Shimizu; Yoshiyuki Yamaguchi; Mikio Oka; Eiichi Nakayama; Andreas Lundqvist; Rolf Kiessling; Barbara Seliger; Masao Nakata
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

10.  KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

Authors:  Yayi He; Paul A Bunn; Caicun Zhou; Dan Chan
Journal:  Oncotarget       Date:  2016-12-13
View more
  1 in total

Review 1.  Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression.

Authors:  Raheleh Moradpoor; Mona Salimi
Journal:  Iran Biomed J       Date:  2020-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.